BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE | N200063 | NALPROPION PHARMACEUTICALS LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Nalpropion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc.. 7 patentsANDA 208043Naltrexone Hydrochloride and Bupropion Hydrochloride | D. Del. | 2015-06-03 | Terminated 2020-10-20 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8088786 | Feb 3, 2029 | — | — | Yes | — | — |
| 8318788 | Nov 8, 2027 | — | — | — | — | |
| 8722085 | Nov 8, 2027 | — | — | — | — | |
| 8916195 | Feb 2, 2030 | — | — | — | — | |
| 9107837 | Jun 4, 2027 | — | — | — | — | |
| 9125868 | Nov 8, 2027 | — | — | — | — | |
| 9248123 | Jan 13, 2032 | — | — | — | — | |
| 9633575 | Jun 25, 2033 | — | — | — | — | |
| 10231964 | Jul 2, 2034 | — | — | — | — | |
| 10307376 | Nov 8, 2027 | — | — | — | — | |
| 10403170 | Jun 5, 2033 | — | — | — | — | |
| 10828294 | Jul 2, 2034 | — | — | — | — | |
| 10835527 | Jul 2, 2034 | — | — | — | — | |
| 11033543 | Jan 10, 2031 | — | — | — | — | |
| 11139056 | Jun 5, 2033 | — | — | — | — | |
| 11324741 | May 29, 2029 | — | — | — | — | |
| 11998542 | Jul 2, 2034 | — | — | — | — | |
| 12048769 | Nov 8, 2027 | — | — | — | — |